Accuray Incorporated (NASDAQ: ARAY) announced today that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is the first in Canada to treat cancer patients using the company's Radixact® radiation therapy delivery system. According to the Quebec Cancer Foundation, "on average in Quebec, someone learns that they have cancer every 8 minutes1," reinforcing the need for innovative new care options like the Radixact System

Pune: Ruby Hall Clinic inaugurates its latest addition: a cutting-edge Intensive Care Unit (ICU), further strengthening its position as a leader in critical care medicine. This new facility, featuring 12 beds, including 2 private ones, marks a significant enhancement to the hospital's existing critical care infrastructure.  The inauguration of the new ICU was made possible through the generous philanthropy of Maharookh and Farrokh N Cooper of Cooper Corporation. The Coopers

Mainstay Medical Holdings plc today announced that the U.S. Food and Drug Administration (FDA) has approved conditional whole-body MRI labeling for the ReActiv8® restorative neurostimulation system. This approval applies to all current and future ReActiv8 patients in the United States implanted with the commercially available 45cm leads. The approval allows patients with ReActiv8 implants to undergo 1.5T whole-body MRIs. Scan specifications and safety informatio

Quality Insights, a non-profit organization with a mission of improving health and healthcare, is actively seeking partnerships to elevate healthcare excellence across the Mid-Atlantic region, covering Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, and West Virginia.  Early this year, Quality Insights will apply for an opportunity to lead collaborative healthcare improvements under the Centers for Medicare & Medicaid Services (CMS) Quality Innovation Netw

ZOLL ® , an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that the ZOLL AED 3 ® defibrillator is approved by the Medical Devices Regulation 2017/745 of the European Union (EU), commonly known as EU MDR. The EU MDR is the European Union Medical Devices Regulation 2017/745, published in 2017 by the European Parliament and the Council of the European Union. The objectiv

Medovate Ltd, an award-winning medical device development company based in Cambridge, and JEB Technologies, an established leader in end-to-end medical device design and manufacturing, proudly announce they have become part of the same group structure that will integrate their management, unique skill sets and expertise to drive greater collaboration, innovation and growth in the dynamic field of medical device development.  This strategic move involves two award-winning compan

OGT, a leading global provider of genomic research and diagnostic solutions, proudly announces the opening of state-of-the-art facilities within the Oxford Technology Park. The move represents a multi-million-pound investment, fuelled by consistent company growth and growing customer demand. Equipped with cutting-edge technology, the facilities will drive development of OGT’s trusted SureSeq™ next generation sequencing (NGS) product portfolio, as well as deliver expert-led trainin

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products. Under the agreement, Cardinal Health will market and distribute Precipio’s HemeScreen portfolio of molecular assays to its customer base, which comprises primarily the acute healthcare systems (hospital networks), as well as reference laboratories and physician owned laboratories. &

IlluminOss Medical, offering a unique, minimally invasive technology for fracture repair and stabilization in geriatric and compromised bone, announced it has reached the important benchmark of enrolling over 200 patients in its global device registry across 16 sites. IlluminOss will highlight the results of the patients in the registry at the upcoming American Academy of Orthopedic Surgeons meeting. To further the evidence of the 1000+ patients' data in peer reviewed publicatio

IONETIX, a leading cyclotron technology and isotope manufacturing company, is pleased to announce the launch of our partnership with Provision Diagnostic Imaging in Knoxville which utilizes N-13 Ammonia manufactured on site by IONETIX. Provision Diagnostic Imaging is a free-standing outpatient diagnostic center, recognized as a regional leader and pioneer rooted in global technology development in medical diagnostics and most often the first to bring innovative and advanced technology to pati